Clinical Research Directory
Browse clinical research sites, groups, and studies.
This Study is to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of HSK47388 in Healthy Volunteers
Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Summary
This is a single-center, randomized, double-blind, placebo-controlled, SAD study to evaluate the safety, tolerability and PK of HSK47388 in healthy adult participants and preliminarily evaluate the PD of HSK47388
Official title: A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HSK47388 in Healthy Volunteers
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2025-05
Completion Date
2025-09
Last Updated
2025-04-13
Healthy Volunteers
Yes
Conditions
Interventions
HSK47388
cohort 1 to cohort 5
Placebo
cohort 1 to cohort 5
Locations (1)
CMAX Clinical Research
Adelaide, Australia